The Market Access and Strategy team at Peregrine Market Access collaborates to develop and implement comprehensive strategies that showcase the value of pharmaceutical and biotechnology products to payers. By leveraging insights, economic modeling, and effective communication, the team aims to ensure that clients' FDA-approved treatments are accessible to patients, thereby reshaping healthcare value in America. They focus on navigating the complexities of market access, enhancing clients' understanding and engagement with critical stakeholders in the healthcare ecosystem.